171 related articles for article (PubMed ID: 20094727)
1. The epidemiology of motor neurone disease in two counties in the southwest of England.
Imam I; Ball S; Wright D; Hanemann CO; Zajicek J
J Neurol; 2010 Jun; 257(6):977-81. PubMed ID: 20094727
[TBL] [Abstract][Full Text] [Related]
2. Changing epidemiology of motor neurone disease in Scotland.
Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
[TBL] [Abstract][Full Text] [Related]
3. The incidence and prevalence of motor neurone disease in South Australia.
Luker J; Woodman R; Schultz D
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):195-202. PubMed ID: 35934980
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019.
McCluskey G; Duddy W; Haffey S; Morrison K; Donaghy C; Duguez S
Eur J Neurol; 2022 Mar; 29(3):707-714. PubMed ID: 34748676
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.
Barceló MA; Povedano M; Vázquez-Costa JF; Franquet Á; Solans M; Saez M
Sci Rep; 2021 Mar; 11(1):6207. PubMed ID: 33737526
[TBL] [Abstract][Full Text] [Related]
6. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological characteristics of motor neuron disease in Chinese patients.
Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of amyotrophic lateral sclerosis.
Kurtzke JF
Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
[TBL] [Abstract][Full Text] [Related]
9. Nationwide incidence of motor neuron disease using the French health insurance information system database.
Kab S; Moisan F; Preux PM; Marin B; Elbaz A
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
[TBL] [Abstract][Full Text] [Related]
10. Motor neurone disease in South Estonia. Diagnosis and incidence rate.
Gross-Paju K; Oöpik M; Lüüs SM; Kalbe I; Puksa L; Lepik T; Kaasik AE
Acta Neurol Scand; 1998 Jul; 98(1):22-8. PubMed ID: 9696523
[TBL] [Abstract][Full Text] [Related]
11. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron disease mortality rates in New Zealand 1992-2013.
Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
[TBL] [Abstract][Full Text] [Related]
13. An all-Ireland epidemiological study of MND, 2004-2005.
Donaghy C; O'Toole O; Sheehan C; Kee F; Hardiman O; Patterson V
Eur J Neurol; 2009 Jan; 16(1):148-53. PubMed ID: 19087159
[TBL] [Abstract][Full Text] [Related]
14. Is the incidence of motor neuron disease higher in French military personnel?
Vlaar T; Elbaz A; Moisan F
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):107-115. PubMed ID: 31621421
[No Abstract] [Full Text] [Related]
15. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
Elian M; Dean G
Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
[TBL] [Abstract][Full Text] [Related]
16. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology.
Huisman MH; de Jong SW; van Doormaal PT; Weinreich SS; Schelhaas HJ; van der Kooi AJ; de Visser M; Veldink JH; van den Berg LH
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1165-70. PubMed ID: 21622937
[TBL] [Abstract][Full Text] [Related]
17. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
Alonso A; Logroscino G; Jick SS; Hernán MA
Eur J Neurol; 2009 Jun; 16(6):745-51. PubMed ID: 19475756
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of motor neurone disease in the Province of Alberta.
Svenson LW; Cwik VA; Martin WR
Can J Neurol Sci; 1999 May; 26(2):119-22. PubMed ID: 10352871
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).
Abhinav K; Stanton B; Johnston C; Hardstaff J; Orrell RW; Howard R; Clarke J; Sakel M; Ampong MA; Shaw CE; Leigh PN; Al-Chalabi A
Neuroepidemiology; 2007; 29(1-2):44-8. PubMed ID: 17898523
[TBL] [Abstract][Full Text] [Related]
20. MND risk factors: an epidemiological study in the north west of England.
Mitchell JD; Davies RB; al-Hamad A; Gatrell AC; Batterby G
J Neurol Sci; 1995 May; 129 Suppl():61-4. PubMed ID: 7595624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
